| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $296.2M | -15.7% |
| R&D Expense | $95.1M | -14.6% |
| SG&A Expense | $82.3M | -43.0% |
| Operating Income | $98.5M | +5.8% |
| Pre-tax Income | $70.0M | +7.4% |
| Income Tax | $46.0M | -28.5% |
| Net Income | $24.0M | +2629.2% |
| EPS (Basic) | $0.15 | +1400.0% |
| EPS (Diluted) | $0.15 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $215.5M | +143.3% |
| Accounts Receivable | $46.7M | -42.9% |
| Current Assets | $274.2M | +50.3% |
| Total Assets | $396.9M | +13.1% |
| Current Liabilities | $242.2M | +523.5% |
| Stockholders' Equity | -$261.8M | +13.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $127.0M | +22.7% |
| Capital Expenditures | $34K | -76.1% |
| Investing Cash Flow | -$34K | +76.1% |
| Financing Cash Flow | $216K | +100.2% |
| Free Cash Flow | $127.0M | +22.8% |
| +1400.0% |